JFLLIFEPharmaceuticals
JFL LIFE SCIENCES — Cash Flow Statement
₹8.55
-4.32%
JFL LIFE SCIENCES Cash Flow Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Free Cash Flow | 2.26 Cr | -9.05 Cr | 0.63 Cr | -7.59 Cr |
| Repayment Of Debt | -1.49 Cr | -8.67 Cr | -0.94 Cr | — |
| Issuance Of Capital Stock | 0.00 | 18.17 Cr | 1.56 Cr | 0.95 Cr |
| Capital Expenditure | -6.10 Cr | — | -1.69 Cr | -1.72 Cr |
| End Cash Position | 0.03 Cr | 0.06 Cr | 0.19 Cr | 0.04 Cr |
| Beginning Cash Position | 0.06 Cr | 0.19 Cr | 0.04 Cr | 0.30 Cr |
| Changes In Cash | -0.03 Cr | -0.12 Cr | 0.15 Cr | -0.26 Cr |
| Financing Cash Flow | -2.31 Cr | 8.07 Cr | -1.46 Cr | 7.25 Cr |
| Interest Paid Cff | -0.83 Cr | -1.42 Cr | -2.08 Cr | -1.20 Cr |
| Net Common Stock Issuance | 0.00 | 18.17 Cr | 1.56 Cr | 0.95 Cr |
| Common Stock Issuance | 0.00 | 18.17 Cr | 1.56 Cr | 0.95 Cr |
| Net Issuance Payments Of Debt | -1.49 Cr | -8.67 Cr | -0.94 Cr | 7.49 Cr |
| Net Long Term Debt Issuance | -1.49 Cr | -8.67 Cr | -0.94 Cr | 7.49 Cr |
| Long Term Debt Payments | -1.49 Cr | -8.67 Cr | -0.94 Cr | — |
| Investing Cash Flow | -6.07 Cr | 0.86 Cr | -0.71 Cr | -1.64 Cr |
| Interest Received Cfi | 0.03 Cr | 0.00 | 0.10 Cr | 0.08 Cr |
| Net Investment Purchase And Sale | 0.00 | 0.62 Cr | 0.88 Cr | — |
| Sale Of Investment | 0.00 | 0.62 Cr | 0.88 Cr | — |
| Net PPE Purchase And Sale | -6.10 Cr | 0.24 Cr | -1.69 Cr | -1.72 Cr |
| Purchase Of PPE | -6.10 Cr | — | -1.69 Cr | -1.72 Cr |
| Operating Cash Flow | 8.36 Cr | -9.05 Cr | 2.32 Cr | -5.87 Cr |
| Taxes Refund Paid | -0.06 Cr | -1.00 Cr | 0.13 Cr | -0.09 Cr |
| Change In Working Capital | 3.36 Cr | -13.63 Cr | -4.05 Cr | -7.93 Cr |
| Change In Other Current Liabilities | 2.77 Cr | -3.44 Cr | 3.99 Cr | -0.19 Cr |
| Change In Other Current Assets | 0.00 | 0.08 Cr | -0.10 Cr | -1.10 Cr |
| Change In Payable | 2.42 Cr | -8.05 Cr | 10.84 Cr | -4.25 Cr |
| Change In Inventory | -3.11 Cr | 2.23 Cr | -9.22 Cr | -1.99 Cr |
| Change In Receivables | 1.27 Cr | -4.45 Cr | -9.56 Cr | -0.41 Cr |
| Other Non Cash Items | 0.80 Cr | 1.42 Cr | 1.98 Cr | 1.12 Cr |
| Depreciation And Amortization | 0.44 Cr | 0.43 Cr | 0.37 Cr | 0.28 Cr |
| Depreciation | 0.44 Cr | 0.43 Cr | 0.37 Cr | 0.28 Cr |
| Pension And Employee Benefit Expense | 0.01 Cr | 0.02 Cr | 0.09 Cr | 0.02 Cr |
| Net Income From Continuing Operations | 3.80 Cr | 3.72 Cr | 3.80 Cr | 0.75 Cr |
| Other Cash Adjustment Outside Changein Cash | — | -0.01 Cr | — | 1000.00 |
| Net Other Financing Charges | — | -0.01 Cr | — | — |
| Sale Of PPE | — | 0.24 Cr | — | — |
| Issuance Of Debt | — | — | — | 7.49 Cr |
| Long Term Debt Issuance | — | — | — | 7.49 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on JFL LIFE SCIENCES
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.